azacitadine
Showing 1 - 4 of 4
Acute Myeloid Leukemia, in Relapse, Acute Myeloid Leukemia Refractory Trial (Venetoclax, Azacitadine, Vorinostat)
Not yet recruiting
- Acute Myeloid Leukemia, in Relapse
- Acute Myeloid Leukemia Refractory
- Venetoclax
- +5 more
- (no location specified)
Apr 11, 2022
Acute Myeloid Leukemia Trial in Baltimore, Chapel Hill, Charleston (pembrolizumab, Azacitadine)
Active, not recruiting
- Acute Myeloid Leukemia
- pembrolizumab
- Azacitadine
-
Baltimore, Maryland
- +2 more
May 19, 2022
Non-Hodgkin Lymphoma (NHL), Multiple Myeloma (MM), Chronic Lymphocytic Leukemia (CLL) Trial in Japan (azacitadine, venetoclax,
Completed
- Non-Hodgkin Lymphoma (NHL)
- +4 more
- azacitadine
- +2 more
-
Nagoya shi, Aichi, Japan
- +13 more
Jul 29, 2021
Acute Myeloid Leukemia Trial in Valencia (Azacitadine, Fludarabine, Cytarabine)
Completed
- Acute Myeloid Leukemia
- Azacitadine
- +4 more
-
Valencia, SpainHospital Universitari i Politècnic La Fe
Apr 3, 2020